0CD.F LIFELINE SPAC I OYJ A EO1
- Market cap
- EUR 139M
- P/E
- -
- P/B
- 1.40x
- ROE
- -9.0%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is 0CD.F undervalued?
Graham numberThe Graham number of LIFELINE SPAC I OYJ A EO1 cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
LIFELINE SPAC I OYJ A EO1 fundamental analysis
No fundamental analysis for LIFELINE SPAC I OYJ A EO1 yet.
LIFELINE SPAC I OYJ A EO1 stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About LIFELINE SPAC I OYJ A EO1
Canatu Oyj develops and sells carbon nanotubes (CNTs) and related products, and manufacturing equipment for the semiconductor, automotive, and medical diagnostics industries in Finland, the United States, Japan, and Taiwan. The company offers custom CNT synthesis reactors; CNT membrane for high-power EUV lithography and X-Ray filter applications; EUV pellicies to protect photomask for contamination while permitting high EUV transmission; optical filters for use in X-Ray filt…
Full company profileLIFELINE SPAC I OYJ A EO1 financial statements
LIFELINE SPAC I OYJ A EO1 annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | 0.00 | 0.00 | 3.30M | 15.6M |
| Gross Profit | -316K | 0.00 | 2.20M | 13.2M |
| Operating Income | -663K | -1.40M | -5.30M | -10.6M |
| EBITDA | -290K | 2.00M | -2.90M | -7.10M |
| Net Income | -1.55M | 2.00M | -3.60M | -9.70M |
| EPS | -0.16 | 0.20 | -0.11 | -0.29 |
| Balance Sheet | ||||
| Total Assets | 102M | 104M | 125M | 118M |
| Total Liabilities | 99.3M | 400K | 11.9M | 9.90M |
| Shareholders' Equity | 2.38M | 104M | 114M | 108M |
| Cash & Short-term Investments | 1.58M | 400K | 97.9M | 22.1M |
| Cash Flow | ||||
| Operating Cash Flow | -453K | -1.20M | -7.00M | -1.10M |
| Capital Expenditure | 0.00 | 0.00 | 1.10M | 5.00M |
| Free Cash Flow | -453K | -1.20M | -8.10M | -6.10M |
| Ratios | ||||
| ROE | -65.2% | 1.9% | -3.2% | -9.0% |
| ROA | -1.5% | 1.9% | -2.9% | -8.2% |
| Net Profit Margin | - | - | -109.1% | -62.2% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
LIFELINE SPAC I OYJ A EO1 dividends
LIFELINE SPAC I OYJ A EO1 has not paid dividends in the last 4 fiscal years.
Who owns LIFELINE SPAC I OYJ A EO1
- Insiders 53.80%
- Institutions 25.29%
- Public & others 20.91%
- Shares outstanding 33.8M
- Free float 29.7M
LIFELINE SPAC I OYJ A EO1 company profile
- Company name
- LIFELINE SPAC I OYJ A EO1
- Ticker
- 0CD.F
- ISIN
- FI4000512496
- Exchange
- Frankfurt Exchange
- Sector
- Basic Materials
- Industry
- Capital Markets
- Employees
- 174
- Fiscal year end
- December
- Address
- Tiilenlyöjänkuja 9A, Vantaa, Finland, 01720
- Website
- canatu.com
About LIFELINE SPAC I OYJ A EO1
Canatu Oyj develops and sells carbon nanotubes (CNTs) and related products, and manufacturing equipment for the semiconductor, automotive, and medical diagnostics industries in Finland, the United States, Japan, and Taiwan. The company offers custom CNT synthesis reactors; CNT membrane for high-power EUV lithography and X-Ray filter applications; EUV pellicies to protect photomask for contamination while permitting high EUV transmission; optical filters for use in X-Ray filter applications; and inspection membranes that enhances quality control by filtering debris from EUV light source and optical paths. It also provides film, advanced driver assistance systems (ADAS) LIDAR, ADAS camera, and headlight heaters, as well as touch sensors in 3D; and electrochemical biosensors and electrochemical sensors, as well as carbon nanotube transistors. Canatu Oyj was founded in 2004 and is headquartered in Vantaa, Finland.
LIFELINE SPAC I OYJ A EO1 management
10- Mr. Juha KokkonenAdvisor · born 1969
- Dr. Maximilian SlawinskiChief Executive Officer · born 1985
- Dr. Albert NasibulinCo-Founder and Member of Technical Advisory Board
- Dr. Hua JiangCo-Founder
- Mr. Mikko VesterinenChief Financial Officer · born 1983
- Mr. Tapani SalminenChief Operations Officer · born 1989
- Mr. Walter BraunChief Technology Officer · born 1967
- Mr. Antti HarmanmaaVice President of Legal & General Counsel · born 1979
- Mr. Bernd MeierChief Marketing Officer
- Ms. Ann-Sofi ReimsVice President of HR · born 1968